Parkman Healthcare Partners’s Arcellx ACLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
174,276
+106,886
| +159% | +$7.04M | 1.32% | 26 |
|
|
2025
Q1 | $4.42M | Buy |
67,390
+22,898
| +51% | +$1.5M | 0.52% | 55 |
|
|
2024
Q4 | $3.41M | Sell |
44,492
-22,000
| -33% | -$1.69M | 0.45% | 56 |
|
|
2024
Q3 | $5.55M | Sell |
66,492
-90,351
| -58% | -$7.55M | 0.71% | 48 |
|
|
2024
Q2 | $8.66M | Buy |
156,843
+245
| +0.2% | +$13.5K | 1.16% | 31 |
|
|
2024
Q1 | $10.9M | Sell |
156,598
-11,664
| -7% | -$811K | 1.34% | 30 |
|
|
2023
Q4 | $9.34M | Sell |
168,262
-35,220
| -17% | -$1.95M | 1.32% | 24 |
|
|
2023
Q3 | $7.3M | Buy |
203,482
+8,222
| +4% | +$295K | 1.34% | 25 |
|
|
2023
Q2 | $6.17M | Buy |
195,260
+47,614
| +32% | +$1.51M | 1.07% | 29 |
|
|
2023
Q1 | $4.55M | Buy |
147,646
+26,553
| +22% | +$818K | 0.99% | 39 |
|
|
2022
Q4 | $3.75M | Sell |
121,093
-18,782
| -13% | -$582K | 1% | 40 |
|
|
2022
Q3 | $2.63M | Sell |
139,875
-38,125
| -21% | -$715K | 0.75% | 51 |
|
|
2022
Q2 | $3.22M | Buy |
+178,000
| New | +$3.22M | 1.19% | 28 |
|